Long-Term Trends In Acute Bronchodilator Responses Over 4 Years In Patients With Mild/moderate To Very Severe COPD: Post-Hoc Analysis Of Data From The Uplift Trial

被引：0
|
作者：
Tashkin, D. P. [1 ]
Li, N. [1 ]
Kleerup, E. [1 ]
Halpin, D. [2 ]
Decramer, M. [3 ]
Celli, B. R. [4 ]
Elashoff, R. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Royal Devon & Exeter Hosp, Exeter, Devon, England
[3] Univ Leuven, Leuven, Belgium
[4] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5974
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Low Occurrence of Colectomy With Long-Term (up to 4 Years) Golimumab Treatment in Patients With Moderate-to-Severe Active Ulcerative Colitis: Data From the PURSUIT Maintenance and Long-Term Extension Studies
    Weinstein, Cindy L. J.
    Meehan, Alan G.
    Govoni, Marinella
    Lin, Jianxin
    Reinisch, Walter
    CROHNS & COLITIS 360, 2023, 5 (03)
  • [22] Low occurrence of colectomy with long-term (up to 4 years) golimumab treatment in patients with moderate-to-severe active Ulcerative Colitis: Data from the PURSUIT maintenance and long-term extension studies
    Weinstein, C. L.
    Meehan, A. G.
    Lin, J.
    Govoni, M.
    Qureshi, Z. P.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I114 - I115
  • [23] Combined Evidence for a Long-Term, Clinical Slowing Effect of Multinutrient Intervention in Prodromal Alzheimer’s Disease: Post-Hoc Analysis of 3-Year Data from the LipiDiDiet Trial
    Suzanne B. Hendrix
    H. Soininen
    A. Solomon
    P. J. Visser
    A. M. J. van Hees
    D. S. Counotte
    J. Nicodemus-Johnson
    S. P. Dickson
    K. Blennow
    M. Kivipelto
    T. Hartmann
    The Journal of Prevention of Alzheimer's Disease, 2023, 10 : 464 - 470
  • [24] Combined Evidence for a Long-Term, Clinical Slowing Effect of Multinutrient Intervention in Prodromal Alzheimer's Disease: Post-Hoc Analysis of 3-Year Data from the LipiDiDiet Trial
    Hendrix, Suzanne
    Soininen, H.
    Solomon, A.
    Visser, P. J.
    van Hees, A. M. J.
    Counotte, D. S.
    Nicodemus-Johnson, J.
    Dickson, S. P.
    Blennow, K.
    Kivipelto, M.
    Hartmann, T.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2023, 10 (03): : 464 - 470
  • [25] Impact of secukinumab on the need for rescue surgical intervention in patients with moderate to severe hidradenitis suppurativa: Post-hoc analysis of week 16 data from sunshine and sunrise trials
    van der Zee, Hessel H.
    Szepietowski, Jacek C.
    Sayed, Christopher
    Guillem, Philippe
    Hamzavi, Iltefat H.
    Goldberg, Stephanie
    Field, Clarice
    Ortmann, Christine-Elke
    Lobach, Iryna
    Wozniak, Magdalena B.
    Llobet-Martinez, Angela
    Ravichandran, Shoba
    Bachhuber, Teresa
    Bechara, Falk G.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 : 30 - 31
  • [26] Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data
    Gottlieb, Alice B.
    Deodhar, Atul
    Mcinnes, Iain B.
    Baraliakos, Xenofon
    Reich, Kristian
    Schreiber, Stefan
    Bao, Weibin
    Marfo, Kwaku
    Richards, Hanno B.
    Pricop, Luminita
    Shete, Abhijit
    Trivedi, Vivek
    Keefe, Deborah
    Papavassilis, Charis C.
    Jagiello, Piotr
    Papanastasiou, Philemon
    Mease, Philip J.
    Lebwohl, Mark
    ACTA DERMATO-VENEREOLOGICA, 2022, 102
  • [27] Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years
    Kimball, A. B.
    Gordon, K. B.
    Fakharzadeh, S.
    Yeilding, N.
    Szapary, P. O.
    Schenkel, B.
    Guzzo, C.
    Li, S.
    Papp, K. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (04) : 861 - 872
  • [28] Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data
    Bykerk, Vivian P. P.
    Nash, Peter
    Nicholls, David
    Tanaka, Yoshiya
    Winthrop, Kevin
    Popova, Christina
    Tilt, Nicola
    Haaland, Derek
    RHEUMATOLOGY AND THERAPY, 2023, 10 (03) : 693 - 706
  • [29] Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data
    Vivian P. Bykerk
    Peter Nash
    David Nicholls
    Yoshiya Tanaka
    Kevin Winthrop
    Christina Popova
    Nicola Tilt
    Derek Haaland
    Rheumatology and Therapy, 2023, 10 : 693 - 706
  • [30] Effects of 8,000 IU aXa long-term prophylaxis with certoparin on the incidence of hyperkalemia in patients with coronary heart disease - A post-hoc analysis of the PARAT trial
    Melzer N.
    Bramlage P.
    Michaelis H.-C.
    BMC Research Notes, 7 (1)
12345